{"id":"W2810837006","doi":"10.1016/j.jval.2018.04.234","title":"Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Cisplatin; Internal medicine; Chemotherapy; Oncology; Cancer; Performance status; Urothelial cancer; Bladder cancer; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004474579,0.0002338462,0.0005207093,0.002110035,0.002166,0.001727272,0.001549699,0.0006308438,0.006664091],"category_scores_gemma":[0.003705011,0.0003327774,0.001049687,0.005895742,0.0007610669,0.00041559,0.001106649,0.001266309,0.0002975633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05500843,"about_ca_system_score_gemma":0.06303037,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9927514,"about_ca_topic_score_gemma":0.9966062,"domain_scores_codex":[0.9981357,0.0001096678,0.0001632193,0.0002301405,0.000546839,0.0008143092],"domain_scores_gemma":[0.9929126,0.000332824,0.001833366,0.00009473586,0.002639765,0.002186743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001945842,0.00005438003,0.973747,0.0001565211,0.0001010957,0.0003033668,0.0007588117,0.0003928985,0.0004324139,0.001115788,0.007558058,0.01518522],"study_design_scores_gemma":[0.00001575499,0.00005044232,0.9886475,0.0002087285,0.0000474379,0.0004092955,0.002316949,0.0005862655,0.0002311452,0.0001077424,0.007350609,0.00002817457],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9377999,0.007200029,0.000357912,0.008619004,0.000106299,0.0001470296,0.02608459,0.0000993711,0.01958581],"genre_scores_gemma":[0.9903917,0.002055032,0.0002670836,0.0007675877,0.0000171296,0.00002164536,0.0031413,0.00003212502,0.003306406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05500843,"threshold_uncertainty_score":0.3991159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07991176340706468,"score_gpt":0.3583793907815765,"score_spread":0.2784676273745119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}